IL36 is a critical upstream amplifier of neutrophilic lung inflammation in mice.
Carolin K KossChristian T WohnhaasJonathan R BakerCornelia TilpMichèl PrzibillaCarmen LernerSilvia FreyMartina KeckCara M M WilliamsDaniel PeterMeera RamanujamJay FineFlorian GantnerMatthew ThomasPeter J BarnesLouise E DonnellyKarim Christian El KasmiPublished in: Communications biology (2021)
IL-36, which belongs to the IL-1 superfamily, is increasingly linked to neutrophilic inflammation. Here, we combined in vivo and in vitro approaches using primary mouse and human cells, as well as, acute and chronic mouse models of lung inflammation to provide mechanistic insight into the intercellular signaling pathways and mechanisms through which IL-36 promotes lung inflammation. IL-36 receptor deficient mice exposed to cigarette smoke or cigarette smoke and H1N1 influenza virus had attenuated lung inflammation compared with wild-type controls. We identified neutrophils as a source of IL-36 and show that IL-36 is a key upstream amplifier of lung inflammation by promoting activation of neutrophils, macrophages and fibroblasts through cooperation with GM-CSF and the viral mimic poly(I:C). Our data implicate IL-36, independent of other IL-1 family members, as a key upstream amplifier of neutrophilic lung inflammation, providing a rationale for targeting IL-36 to improve treatment of a variety of neutrophilic lung diseases.
Keyphrases
- oxidative stress
- type diabetes
- sars cov
- machine learning
- liver failure
- intensive care unit
- metabolic syndrome
- signaling pathway
- clinical trial
- skeletal muscle
- deep learning
- hepatitis b virus
- cancer therapy
- epithelial mesenchymal transition
- acute respiratory distress syndrome
- big data
- extracorporeal membrane oxygenation
- binding protein
- respiratory failure
- data analysis